Staffeldt, L.; Mattert, G.; Riecken, K.; Rövenstrunk, G.; Volkmar, A.; Heumann, A.; Moustafa, M.; Jücker, M.; Fehse, B.; Schumacher, U.;
et al. Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation. Cells 2024, 13, 82.
https://doi.org/10.3390/cells13010082
AMA Style
Staffeldt L, Mattert G, Riecken K, Rövenstrunk G, Volkmar A, Heumann A, Moustafa M, Jücker M, Fehse B, Schumacher U,
et al. Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation. Cells. 2024; 13(1):82.
https://doi.org/10.3390/cells13010082
Chicago/Turabian Style
Staffeldt, Lisa, Gregor Mattert, Kristoffer Riecken, Götz Rövenstrunk, Anika Volkmar, Asmus Heumann, Mohamed Moustafa, Manfred Jücker, Boris Fehse, Udo Schumacher,
and et al. 2024. "Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation" Cells 13, no. 1: 82.
https://doi.org/10.3390/cells13010082
APA Style
Staffeldt, L., Mattert, G., Riecken, K., Rövenstrunk, G., Volkmar, A., Heumann, A., Moustafa, M., Jücker, M., Fehse, B., Schumacher, U., Lüth, S., & Kah, J.
(2024). Generating Patient-Derived HCC Cell Lines Suitable for Predictive In Vitro and In Vivo Drug Screening by Orthotopic Transplantation. Cells, 13(1), 82.
https://doi.org/10.3390/cells13010082